• A post-market, single-center, randomized, double-blind, cross-over, prospective clinical study of the mild® procedure vs. sham in subjects with painful lumbar spinal stenosis. The objectives of this study are to assess the procedure feasibility, safety and functional outcomes in symptomatic subjects.
• A multi-center, open label, prospective clinical study to assess the clinical application and functional outcomes of symptomatic patients undergoing the Minimally Invasive Lumbar Decompression (mild®) treatment for lumbar spinal stenosis.
• A prospective, multi-center, open label, non-significant risk feasibility study focused on Spinal Cord Stimulation (SCS) implant candidates for the treatment of chronic low back pain. The objective is to evaluate if physical activity and posture parameters can be used as an objective measure of SCS therapy.

Dr. Grigsby is a co-investigator on the following clinical studies:

• Implantable System Performance Registry (ISPR): A clinical registry that monitors the use and performance of the Medtronic Inc. implantable pain relieving devices.
• A 12-week multicenter randomized, double-blind, controlled evaluation of the efficacy, safety and tolerability of NGX-1998 for the treatment of postherpetic neuralgia (PHN).

If you are interested in learning more about our open research studies please contact Whitney Michiels, Research Coordinator, at 707-252-9606